Low rate of asymptomatic cerebral embolism and improved procedural efficiency with the novel pulmonary vein ablation catheter GOLD: results of the PRECISION GOLD trial

Conclusion
Atrial fibrillation ablation with PVAC GOLD in combination with established embolic lowering manoeuvres results in a low incidence of ACE. Pulmonary vein ablation catheter GOLD demonstrates improved biophysical efficiency compared with platinum PVAC.

Trial registration
ClinicalTrials.gov NCT01767558.

Source: Europace - May 24, 2016 Category: Cardiology Authors: De Greef, Y., Dekker, L., Boersma, L., Murray, S., Wieczorek, M., Spitzer, S. G., Davidson, N., Furniss, S., Hocini, M., Geller, J. C., Csanadi, Z., for the PRECISION GOLD investigators Tags: Ablation for atrial fibrillation Source Type: research